Research in Social and Administrative Pharmacy
Volume 2, Issue 1 , Pages 129-142 , March 2006

Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life

  • Brian J. Isetts, Ph.D., B.C.P.S.

      Affiliations

    • Department of Pharmaceutical Care & Health Systems at the University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA
    • Corresponding Author InformationCorresponding author. University of Minnesota College of Pharmacy, Weaver Densford Hall, Room 7-175, 308 Harvard Street, SE, Minneapolis, MN 55455, USA. Tel.: +1 612 624 2140; Fax: 612-625-9931.
    • ,
  • Stephen W. Schondelmeyer, Pharm.D., Ph.D.

      Affiliations

    • Department of Pharmaceutical Care & Health Systems at the University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA
    • ,
  • Alan H. Heaton, Pharm.D.

      Affiliations

    • Blue Cross and Blue Shield of Minnesota, Eagan, MN 55121, USA
    • ,
  • Wallace B. Wadd, Pharm.D.

      Affiliations

    • Prime Therapeutics, LLC, Eagan, MN 55121, USA
    • ,
  • Nancy A. Hardie, M.P.H., M.S.

      Affiliations

    • University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA
    • ,
  • Margaret B. Artz, Ph.D.

      Affiliations

    • Department of Pharmaceutical Care & Health Systems at the University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA
    • Dr Artz was supported by the VFW Endowed Chair in Pharmacotherapy for the Elderly, College of Pharmacy, University of Minnesota.

References 

  1. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003;163:1813–1820
  2. Mikeal RL, Brown TP, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Hosp Pharm. 1975;32:567–574
  3. Smith WE, Benderev K. Levels of pharmaceutical care: a theoretical model. Am J Hosp Pharm. 1991;48:540–546
  4. Hepler DC, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–543
  5. Medicare Payment Advisory Commission, Hackbarth GM (Chair). Report to the congress: Medicare coverage of nonphysician practitioners. Washington, DC, June 2002:21–6.
  6. Public Law No. 108-173: Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
  7. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project impact: hyperlipidemia. J Am Pharm Assoc. 2000;40:157–173
  8. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149–159
  9. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management. The study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med. 2002;162:1149–1155
  10. Erickson SR, Slaughter MS, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy. 1997;17:140–147
  11. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with dyslipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713–719
  12. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes (Cochrane Review). The Cochrane Library. issue 1. Oxford, UK: Update Software; 2004;Accessed 04.07.04
  13. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–270
  14. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–2018
  15. Chiquette E, Amoato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641–1647
  16. Kaushal R, Bates DW. The clinical pharmacist's role in preventing adverse drug events. In:  Shojania K,  Duncan B,  McDonald K,  Wachter RM editor. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Rockville, Md: Agency for Healthcare Research and Quality; 2001;[chapter 7]. Evidence Report/Technology Assessment No. 43; AHRQ publication 01-E058
  17. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med. 1999;159:1939–1945
  18. Cranor CW, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173–184
  19. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services—1996-2000. Pharmacotherapy. 2003;23:113–132
  20. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997;54:554–558
  21. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluation of clinical pharmacy service—1988-1995. Pharmacotherapy. 1996;16:1188–1208
  22. Hatoum HT, Akhras K. 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother. 1993;27:1106–1119
  23. Hatoum HT, Catizone C, Hutchinson RA, Purohit A. Eleven year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm. 1986;20:33–48
  24. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists—2003. Pharmacotherapy. 2003;23:1210–1225
  25. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician's Guide. McGraw-Hill; 2004;
  26. Isetts BJ, Sorensen TD. Use of a student-driven, university-based pharmaceutical care clinic to define the highest standards of patient care. Am J Pharm Educ. 1999;63:443–449
  27. Agency for Healthcare Research and Quality . CAHPS® and the National CAHPS® Benchmarking Database: AHRQ Publication 03-P001. Available from: <http://www.ahrq.gov/qual/cahps/cahpfact.pdf/>2003;Accessed 12.20.04
  28. National Committee for Quality Assurance . Trending CAHPS® 2.0H and CAHPS®3.0H Survey Results. Available from: <http://www.ncqa.org/publications/CAHPS%20TrendingDocumentFinal2403.pdf/>2003;Accessed 04.07.04
  29. National Committee for Quality Assurance . National CAHPS® Benchmarking Database. Available from: <http://ncbd.cahps.org/pdf/NCBD2003Chartbook.pdf/>2003;Accessed 04.07.04
  30. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–629
  31. Wiederholt JB. Development of an instrument to measure evaluative criteria that patients use in selecting a pharmacy for obtaining prescription drugs. J Pharm Mark Manage. 1987;1:35
  32. MacKeigan LD, Larson LN. Development and validation of an instrument to measure patient satisfaction with pharmacy services. Med Care. 1989;27:522–536
  33. Starfield B, Weiner J, Mumford L, Steinwachs D. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991;26:53–74

☆ This project was supported by a grant from the University of Minnesota, Academic Health Center/Fairview Health System, Joint Funding Program.Preliminary project results were presented at the Blue Cross Blue Shield Association, Best Practices in Medical and Pharmacy Management meeting, Chicago, Ill, October 9, 2003. Wadd WB, Heaton AH, Isetts BJ. Measuring the Impact of Collaborative Pharmaceutical Care, BCBSA—Best Practices in Medical and Pharmacy Management.

PII: S1551-7411(05)00131-2

doi: 10.1016/j.sapharm.2005.12.002

Research in Social and Administrative Pharmacy
Volume 2, Issue 1 , Pages 129-142 , March 2006

Article Tools

* Image Usage & Resolution